✦ LIBER ✦

Aflibercept in the Treatment of Neovascular Age-Related Macular Degeneration in Previously Treated Patients

✍ Scribed by Hall, Laura B.; Zebardast, Nazlee; Huang, John J.; Adelman, Ron A.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Cost-Effectiveness of Intravitreal Aflib

✍ Clements, K.M.; Hulbert, E.M.; Panchmatia, H.R.; Eriksson, M.; Wittrup-Jensen, K 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 60 KB

Aflibercept for the Treatment of Age-Rel

✍ George Trichonas, Peter K. Kaiser 📂 Article 📅 2013 🏛 Springer Healthcare Communications 🌐 English ⚖ 416 KB

Cost-Effectiveness Of Intravitreal Aflib

✍ Vitti, R.; Clements, K.M.; Panchmatia, H.; Hulbert, E.; Wittrup-Jensen, K.; Lewi 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 72 KB

Short-Term Outcomes of Aflibercept for N

✍ Ho, Vincent Y.; Yeh, Steven; Olsen, Timothy W.; Bergstrom, Chris S.; Yan, Jiong; 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 782 KB

Clinical outcomes after switching treatm

✍ Heussen, Florian M.; Shao, Qing; Ouyang, Yanling; Joussen, Antonia M.; Müller, B 📂 Article 📅 2013 🏛 Springer-Verlag 🌐 English ⚖ 478 KB

Aflibercept in Neovascular (Wet) Age-Rel

✍ Brown, A.; Ferreira, A.; Lamle, S.; Milnes, F. 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 57 KB